After Launching World’s First TriChroma Laser TV L9 Series, Hisense Now Brings the Series’ 100L9G to Africa

CAPE TOWN, South Africa, Jan. 14, 2022 /PRNewswire/ — Hisense, provider of high-performance televisions and appliances, has announced the world’s first 100-inch L9G TriChroma Laser TV featuring 4K UHD resolution, 107% BT 2020 Colour Gamut, and Dolby Atmos® speaker system, is now available in Africa. Following the introduction of the world’s first Dual Colour 4K Laser TV to Africa, […]

Sungrow and KarmSolar Cooperate on the Microgrid BESS Project for Cairo 3A Group

CAIRO, Jan. 14, 2022 /PRNewswire/ — Recently, Sungrow, the global leading inverter solution supplier for renewables, signed a new BESS contract with KarmSolar, Egyptian largest private sector solar energy provider. Sungrow will provide 2.576MWp PV inverter and 1MW/3.957 MWh energy storage system to build a microgrid for Cairo 3A Poultry Company. This microgrid, by its […]

U.S. Institute of Peace Nominations Are Open for the 2022 Women Building Peace Award

Annual award recognizes women peacebuilders from conflict-affected countries. WASHINGTON, Jan. 13, 2022 /PRNewswire/ — The U.S. Institute of Peace (USIP) announces nominations are open for the 2022 Women Building Peace Award. This prestigious annual award honors women who are building peace in countries impacted by violent conflict. The nominations period will run until February 14, 2022. The […]

Adagio Therapeutics Divulga Resumo da Atividade Neutralizante do ADG20 Contra Variantes do SARS-CoV-2 e Descreve Iniciativas para Abordar o Omicron

Publicações recentes de vários laboratórios independentes mostram que o ADG20 tem atividade neutralizante com potência comparável a outros anticorpos que retêm atividade contra o Omicron Múltiplos Esforços em Andamento para Abordar Variantes Omicron e Potenciais Futuras de SARS-CoV-2 WALTHAM, Mass., Jan. 13, 2022 (GLOBE NEWSWIRE) — A Adagio Therapeutics, Inc., (Nasdaq: ADGI), uma empresa biofarmacêutica […]

Adagio Therapeutics résume l’activité neutralisante de l’ADG20 contre les variants du SARS-CoV-2 et décrit ses initiatives visant à contrer Omicron

Des publications récentes de plusieurs laboratoires indépendants montrent que l’ADG20 a une activité neutralisante présentant une puissance comparable à d’autres anticorps et qui reste active contre Omicron Plusieurs initiatives sont en cours pour traiter Omicron et les futurs variants potentiels du SARS-CoV-2 WALTHAM, Massachusetts, 14 janv. 2022 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., (Nasdaq : ADGI), […]

Date limite de participation finale prolongée lors des Prix Stevie® 2022 pour les ventes et le service à la clientèle

Les participants peuvent soumettre leurs candidatures jusqu’au 2 février aux prix des meilleures ventes et du service à la clientèle FAIRFAX, Virginie, 13 janv. 2022 (GLOBE NEWSWIRE) — À la demande générale, les Prix Stevie® ont prolongé la date limite de participation finale de la 16e édition annuelle des Prix Stevie® pour les ventes et le […]